Form 4: Quest Diagnostics SVP Mark Delaney Reports Stock Disposition for Tax Obligations

Mark Delaney, SVP & Chief Commercial Officer of Quest Diagnostics, disposed of 256 shares of common stock to cover tax withholding obligations arising from vesting of restricted stock units.

Summary

• Mark E. Delaney, SVP & Chief Commercial Officer of Quest Diagnostics, filed a Form 4 on March 28, 2025.
• The filing reports a transaction that occurred on March 26, 2025.
• Delaney disposed of 256 shares of Quest Diagnostics common stock at a price of $166.71 per share.
• This disposition was to cover tax withholding obligations related to the vesting of restricted stock units.
• Following the transaction, Delaney directly owns 9,221 shares of Quest Diagnostics common stock.

Sentiment

Score: 5

Explanation: This is a neutral event. It's a standard transaction for covering tax obligations and doesn't indicate a change in the executive's confidence in the company.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This transaction is a common occurrence where executives sell shares to cover tax obligations related to vesting equity.

Key Dates

Keywords

Form 4, Quest Diagnostics, Mark Delaney, Stock Disposition, Tax Withholding, Restricted Stock Units, DGX, Beneficial Ownership